𝗥𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗻𝗴 𝗼𝗻 𝗔𝗔𝗧𝗠 𝟮𝟬𝟮𝟯 𝗮𝗻𝗱 𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗔𝗵𝗲𝗮𝗱 𝘁𝗼 𝟮𝟬𝟮𝟱 In 2023, AATM brought together over 80 participants and 22 expert speakers from the FDA, top pharmaceutical companies, and academia. The event sparked valuable discussions and set the stage for shaping the future of pharmaceutical development. In 2025, we are building on the success of 2023. Join us in Washington, DC on April 1-2, where 25 distinguished speakers will lead sessions on the solutions accelerating access to medicines. Expect to hear from leaders like Prof. Johannes Khinast (RCPE / Graz University of Technology), Luca Emili (InsilicoTrials), and Matthew M. Bio, Ph.D. (Snapdragon Chemistry, a Cambrex Company). We will cover critical topics such as: • Drug Substance: APIs & Biologics • Drug Product: From Pills to Injectables • Derisking Supply Chains & Transatlantic Partnerships • Modeling & Simulation: From Molecules to Products With around 120 industry professionals, regulators, and decision-makers in attendance, AATM 2025 will be your opportunity to connect and gain actionable insights for driving the future of pharmaceuticals. Find out more and register here: https://lnkd.in/dWWBMKyg #AATM2025 #PharmaInnovation #PharmaceuticalDevelopment
